Screener
Krystal Biotech, Inc. KRYS Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Krystal Biotech, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 7:06 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001711279-26-000043
FAQ
- What is Krystal Biotech, Inc.'s current ratio?
- Krystal Biotech, Inc. (KRYS) reported current ratio of 9.5× in Q1 2026.
- How has Krystal Biotech, Inc.'s current ratio changed year-over-year?
- Krystal Biotech, Inc.'s current ratio decreased by 1.9% year-over-year, from 9.6× to 9.5×.
- What is the long-term trend for Krystal Biotech, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s current ratio has grown at a -11.0% compound annual growth rate (CAGR), from 17.8× to 10×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Krystal Biotech, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude